Patents by Inventor ASHWIN GOLLERKERI

ASHWIN GOLLERKERI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IRAK4 DEGRADERS AND USES THEREOF
    Publication number: 20230277519
    Abstract: The present invention relates to IRAKIMiD degraders, their liquid formulations, and methods of use thereof for treating cancer.
    Type: Application
    Filed: January 13, 2023
    Publication date: September 7, 2023
    Inventors: Jared Gollob, Jeffrey Davis, Ashwin Gollerkeri, Reginald EWESUEDO, Alice McDonald, Vashali Dixit, Shu-Pei Wu, Michele Mayo, Haojing Rong, Sagar Agarwal, Bradley Enerson, Patrick Henrick, Rachelle Perea, Christopher Ho, William Leong, Duncan Walker
  • TREATMENT WITH ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES
    Publication number: 20180099054
    Abstract: The present invention provides for dosing regimens for the treatment of patients with cancer and/or an EFNA4-associated disorder with an anti-EFNA4 antibody-drug conjugate (ADC). The present invention further provides for methods for the treatment of patients with cancer and/or an EFNA4-associated disorder in which an anti-EFNA4 ADC is administered intravenously weekly (QW) or every 3 weeks (Q3W).
    Type: Application
    Filed: May 12, 2016
    Publication date: April 12, 2018
    Applicants: PFIZER INC., RINAT NEUROSCIENCE CORP.
    Inventors: ASHWIN GOLLERKERI, KAREN VELASTEGUI, RAFFAELE BAFFA, JAYMES SCOT HOLLAND